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The mammalian cilium protrudes from the api-
cal/lumenal surface of polarized cells and acts
as a sensor of environmental cues. Numerous
developmental disorders and pathological con-
ditions have been shown to arise from defects
in cilia-associated signaling proteins. Despite
mounting evidence that cilia are essential sites
for coordination of cell signaling, little is known
about the cellular mechanisms controlling their
formation and disassembly. Here, we show that
interactions between the prometastatic scaf-
folding protein HEF1/Cas-L/NEDD9 and the on-
cogenic Aurora A (AurA) kinase at the basal
body of cilia causes phosphorylation and acti-
vation of HDAC6, a tubulin deacetylase, pro-
moting ciliary disassembly. We show that this
pathway is both necessary and sufficient for
ciliary resorption and that it constitutes an un-
expected nonmitotic activity of AurA in verte-
brates. Moreover, we demonstrate that small
molecule inhibitors of AurA and HDAC6 selec-
tively stabilize cilia from regulated resorption
cues, suggesting a novel mode of action for
these clinical agents.
INTRODUCTION
In polycystic kidney disease (PKD), Bardet-Biedl Syn-
drome (BBS), and other disorders, mutations in cilia-asso-
ciated structural or signaling proteins cause insensitivity
to external mechanical and diffusible signaling cues, re-
sulting in disorganized, hyperplastic cell growth (Benzing
and Walz, 2006; Pan et al., 2005; Singla and Reiter,
2006). On the organismal level, ciliary defects produce
renal cysts, infertility, respiratory disorders, situs inversus,
and predisposition to obesity, diabetes, and hypertension.
Notably, recent studies have shown that the Hedgehog,
Wnt, PDGFaa, and other signaling cascades are coordi-nated at cilia (Cano et al., 2004; Huangfu and Anderson,
2005; Liu et al., 2005; Schneider et al., 2005; Simons
et al., 2005; Tanaka et al., 2005). The frequent deregula-
tion of these pathways during cell transformation, together
with the common disappearance of cilia in transformed
cells, raises the possibility that defective ciliary signaling
may promote cancer.
Although an increasing number of proteins are being de-
fined as ciliary structural components or cilia-associated
signaling proteins, very little is currently known about the
cellularmachinery controlling the formation and resorption
of cilia. It has long been known that cilia are regulated
dynamically throughout the cell cycle. In many cells, re-
sorption occurs at mitotic entry, and reappearance after
progression into G1. However, resorption is not solely
linked to mitotic entry, with some cells undergoing waves
of resorption at different points in cell cycle: for example,
Tucker et al. have noted ciliary resorption as cells emerge
from quiescence, prior to S-phase (Quarmby and Parker,
2005; Rieder et al., 1979; Tucker et al., 1979). Given their
increasingly apparent role in detecting and transmitting
extracellular signals, regulated formation, disassembly, or
shortening of cilia may play an important role in cellular
growth controls, serving as a rheostat to limit response
to overly persistent or abnormal cell growth cues in the
extracellular environment.
A cilium arises from a basal body, a structure that differ-
entiates from one of the centrioles in the centrosome in
nonproliferating cells and organizes the microtubule bun-
dles that constitute the ciliary axoneme. Cilia are evolu-
tionarily related to the motile flagella of lower eukaryotes,
such as the green algaeChlamydomonas.Genetic studies
in Chlamydomonas have recently begun to dissect the
process of flagellar resorption (Bradley and Quarmby,
2005;Marshall et al., 2005; Pan and Snell, 2005; Quarmby,
2004). These studies have identified altered functionality
of the intraflagellar transport (IFT) machinery and destabi-
lization of the axoneme as hallmarks of disassembly, and
implicated CALK and other kinases as regulators of disas-
sembly. The means by which CALK becomes activated at
initiation of disassembly and the critical CALK effectors in
the disassembly process remain unknown, as does the
relevance of these observations to higher eukaryotes.Cell 129, 1351–1363, June 29, 2007 ª2007 Elsevier Inc. 1351
Figure 1. Activation of AurA at the Basal Body Occurs during Ciliary Disassembly
(A) Assembly of cilia. An average of 200 cells were counted in two independent experiments, error bars show the SD.
(B) Disassembly of cilia induced by serum stimulation. An average of 150 cells were counted in each of four experiments, error bars show the SD.
(C) Immunofluorescence of quiescent cells with antibody to AurA (green), acetylated a-tubulin (blue), and DNA (red). The scale bar represents 10 mm.
In this and subsequent panels, boxes in main image indicate structures shown at high magnification to right.
(D) Immunofluorescence of quiescent cells with polyclonal rabbit antibody to HEF1 (green), also visualizing acetylated a-tubulin (blue), and DNA (red);
compare also to (E). The scale bar represents10 mm.
(E) Immunofluorescence of quiescent cells with monoclonal antibody to HEF1 (green), also visualizing g-tubulin (blue) and DNA (red). The scale bar
represents 5 mm. See also Figure S3A.
(F) Immunofluorescence of quiescent cells with antibody to phospho-Aura (green), acetylated a-tubulin (blue), and DNA (red). The scale bar repre-
sents 12.5 mm.1352 Cell 129, 1351–1363, June 29, 2007 ª2007 Elsevier Inc.
CALK is very distantly related to the human Aurora A
(AurA) kinase, with 55% similarity centered on the protein
catalytic domain. In humans, Aurora A (AurA) is a centroso-
mal kinase that regulates mitotic entry through activation
of Cdk1-cyclin B and other substrates that organize the
mitotic spindle (Bischoff et al., 1998; Marumoto et al.,
2005). AurA amplification or activation is common in
many cancers characterized by centrosomal amplification
and genomic instability (Anand et al., 2003; Goepfert et al.,
2002; Gritsko et al., 2003). In the past 2 years, altered ex-
pression of the HEF1 (Law et al., 1996; O’Neill et al., 2000)
scaffolding protein by amplification or epigenetic means
has been identified as part of a prometastatic signature
in breast cancer (Minn et al., 2005), shown to contribute
to the aggressiveness of glioblastomas (Natarajan et al.,
2006), and found to be critical for progression to metasta-
sis in melanomas (Kim et al., 2006). Although HEF1 is best
known as a transducer of integrin-initiated attachment,
migration, and antiapoptotic signals at focal adhesions
(O’Neill et al., 2000), we have recently documented inter-
actions between HEF1 and AurA at the centrosome that
are necessary for cellular progression through mitosis
(Pugacheva and Golemis, 2005, 2006).
In this study, we demonstrate that an association be-
tween AurA and HEF1 at cilia in response to extracellular
cues is required for ciliary disassembly. We also show
that AurA activation is independently sufficient to induce
rapid ciliary resorption, and that AurA acts in this process
through phosphorylating HDAC6, thus stimulating
HDAC6-dependent tubulin deacetylation (Hubbert et al.,
2002) and destabilizing the ciliary axoneme. Importantly,
our identification of a spatiotemporally restricted action
of AurA at the ciliary basal body in cells emerging from
G0 demonstrates an unexpected nonmitotic activity for
AurA in vertebrate cells. We also determine that small mol-
ecule inhibitors of AurA and HDAC6 reduce regulated
disassembly of cilia, which may have important implica-
tions for the action of these drugs in the clinic. Together,
these data reveal important activities for HEF1, AurA, and
HDAC6 in regulation of ciliary resorption, which should
also inform the actions of these proteins in the cell cycle
and cancer (Hideshima et al., 2005; Kim et al., 2006;
Marumoto et al., 2005; Pugacheva and Golemis, 2005).
RESULTS
A System for Regulated Ciliary Assembly
and Disassembly
We established a system to study ciliary dynamics in the
hTERT-RPE1 cell line. 48 hr after plating cells at 50%–70%confluence in Opti-MEM medium without serum, >80%
of hTERT-RPE1 cells had clearly visible cilia (Figure 1A).
Cilia were typically of 3–4 mm length, with an acetylated
a-tubulin-marked axoneme adjacent to two g-tubulin-
positive structures reflecting the basal body and the sec-
ond cellular centriole (Figure S1A in the Supplemental
Data available with this article online). Treatment of these
ciliated cells with medium containing 10% fetal bovine
serum (FBS) caused ciliary disassembly over the following
24 hr (Figure 1B). This disassembly occurred in twowaves,
with the first occurring 1–2 hr after serum stimulation and
the second after 18–24 hr. FACS analysis, BrDU staining,
and observation of condensed DNA and mitotic figures
indicated that cells remained predominantly in G1 phase
at 2 hr after serum addition, while during the 18–24 hr dis-
assembly wave, most cells were entering mitosis (Figures
S1B and S1C). This disassembly behavior was not unique
to hTERT-RPE1 cells, as we observed a comparable bi-
phasic resorption profile in the IMCD-3 murine and Caki-1
human renal cell lines (Figures S1D and S1E). To begin to
assess serum components that might regulate ciliary dis-
assembly, we have assessed PDGF, TGF-b, and EGF (Fig-
ure S2). Of these, only PDGF elicited a partial response.
Full disassembly likely requires the combined input of
several distinct serum components.
Dynamic Regulation of HEF1 and AurA at the Basal
Body during Ciliary Disassembly
AurA (Figure 1C) and HEF1 (Figures 1D and 1E) localized
to the basal body and the second centriole in quiescent,
ciliated hTERT-RPE1 cells. In contrast, activated (T288-
phosphorylated) AurA was not detected at basal bodies
of cilia in quiescent cells (Figure 1F and 1I [0 hr]) under fix-
ation conditions at which it was clearly evident in mitotic
cells (Figure 1G).
If AurA were functionally important for ciliary disassem-
bly, we would expect changes in the activity of AurA
1–2 hr after serum treatment, potentially accompanied
by changes in the AurA activator HEF1. Indeed, HEF1
expression increased at 1–2 hr after serum stimulation,
dropped, and peaked again at 18–24 hr after serum
stimulation (Figure 1H). HEF1 initially appeared as a faster
migrating 105 kDa species, with a slower migrating 115
kDa species appearing later. This 115 kDa species repre-
sents S/T-phosphorylated HEF1, is most abundant during
the G2/M compartment in actively cycling cells, and is as-
sociatedwith AurA activation (Law et al., 1998; Pugacheva
and Golemis, 2005). Total AurA levels sometimes in-
creased slightly at 2 hr after serum stimulation, but were
largely unaffected (Figures 1H). In contrast, peaks of(G) Immunofluorescence of serum-stimulated cells with antibody to phospho-Aura (green), acetylated a-tubulin (blue), and DNA (red). The scale bar
represents 5 mm.
(H) Western analysis of AurA and HEF1 in hTERT-RPE1 cells after serum stimulation. Western blots shown represent strips and reprobes of a single
gel. Highermolecular weight HEF1 band reflects hyperphosphorylation, and coincides with AurA activation and ciliary disassembly at 2 and 24 hr after
serum addition (at time point 0). Light gray arrow indicates crossreactivity of phospho-AurA directed antibody with total AurA; black arrow indicates
phospho-AurA. See also Figure S1H.
(I) Immunofluorescence depicting AurA activation in serum-stimulated cells during disassembly of cilia. All images are merged panels of acetylated
a-tubulin (red), phospho-AurA or total AurA (green) and DNA (blue).Cell 129, 1351–1363, June 29, 2007 ª2007 Elsevier Inc. 1353
Figure 2. Activation of AurA Is Necessary for Ciliary Resorption
(A) Disassembly of cilia in cells treated with siRNA to AurA or HEF1, or with Scrambled (Scr) control siRNA, for 0 to 24 hr after serum addition. Assay
performed three times, with an average of 100 cells counted/experiment by acetylated tubulin staining, error bars show SD. Results were confirmed
using a second antibody (anti-glutamylated tubulin) to independently score cilia following depletion (Figures S4D and S4E).
(B) Ciliary disassembly was induced in ciliated cells pretreated with control (Scr), AurA-targeted (siA), or HEF1-targeted (siH) siRNA by supplementing
growth media with serum. At 2, 12, and 24 hr after addition of serum, AurA was immunoprecipitated and used for an in vitro kinase assay as in
(Pugacheva and Golemis, 2005). Shown, 32P-labeled phosphorylated histone H3 (top) and total histone H3 in the reaction (stained with Coomassie
Blue, bottom).
(C) Length of cilia in untreated hTERT-RPE1 cells (–), or the hTERT-RPE1 cells treated with control (Scr) or HEF1 targeting siRNA, at the indicated time
points, error bars show the SD.
(D) Ciliated hTERT-RPE1 cells were treated with AurA inhibitor (PHA-680632) or DMSO, then disassembly of cilia tracked for 24 hr after serum
addition, error bars show the SD. The in vitro IC50 of PHA-680632 is 27 nM for AurA; this compound also less potently inhibits AurC, AurB, and1354 Cell 129, 1351–1363, June 29, 2007 ª2007 Elsevier Inc.
phospho-T288-AurA appeared precisely at each of the two
waves of ciliary disassembly (Figures 1H and 1I). Strik-
ingly, phospho-T288-AurA was almost never detected at
a basal body near a well-formed cilium. Although phos-
pho-T288-AurA invariably colocalized with both g-tubulin-
marked basal bodies/centrioles and with total AurA, in
85%–90% of cells with phospho-T288-AurA, centrioles
had no accompanying cilium. In 10%–15% of cells with
phospho-T288-AurA, centrioles with adjacent acetylated
a-tubulin-marked cilia were observed, but these cilia
were significantly shortened (1–2 versus 3.5 mm) (Fig-
ure 1I). Similar profiles of HEF1 and AurA expression and
activation were observed in serum-treated IMCD3 and
Caki-1 cells, and PDGF-treated hTERT-RPE1 cells (Fig-
ures S2B, 2C, 2F, and 2G). The simplest interpretation of
these results is that activation of AurA at the basal body
immediately precedes the rapid disassembly of cilia.
HEF1-Dependent Activation of AurA Induces
Ciliary Disassembly
Weused two complementary approaches to establish that
AurA activation is necessary and sufficient for induction of
ciliary disassembly, and that HEF1 is likely to contribute to
this process. First, exponentially growing hTERT-RPE1
cells were treated with siRNA targeting AurA or HEF1, or
with control siRNA, plated for 2 days in OptiMEM to allow
cilia formation, then treated with serum to induce ciliary
disassembly. Immunoblotting confirmed siRNA treatment
efficiently depleted AurA and HEF1 (Figure S4A). AurA
depletion blocked and HEF1 depletion greatly limited
serum-induced disassembly (Figure 2A). AurA activation
was substantially reduced in cells treated with siRNA to
HEF1 (Figure 2B); this correlated with reduced levels of
AurA in HEF1-depleted cells (Figure S4B), implying HEF1
contributes to AurA stabilization as well as activation. Par-
ticularly at the second wave of ciliary disassembly, the re-
sidual cilia in HEF1-depleted cells were significantly longer
than those in control cells (Figure 2C), implying that HEF1
modulates the disassembly process. Importantly, cells
treated with siRNA to AurA or HEF1, or with control siRNA,
were all80%ciliated before addition of serum, leading us
to conclude that the predominant role for HEF1 and AurA
is at the time of disassembly, i.e., these proteins are not
required to form cilia.
Second, we used the small molecule AurA kinase inhibi-
torPHA-680632 (NervianoMedical Sciences [Soncini et al.,
2006]) to inactivate AurA kinase (Figures 2D and 2E).Disassembly of cilia was strongly reduced in cells
pretreated for 2 hr with 500 nM PHA-680632 (Figure 2D).
Although some ciliary disassembly was observed at 1
and 2 hr after serum stimulation, the percentagewas lower
than in DMSO-treated cells, and disassembly was not
maintained, with cilia consistently re-established at the
8- and 12 hr time points. The second wave of ciliary disas-
sembly, at the time of mitosis, was completely eliminated
in PHA-680632-treated cells (Figure 2D). In cells with
inhibited AurA, hyperphosphorylated HEF1 did not accu-
mulate significantly at either wave of ciliary disassembly,
indicating AurA dependence of this phosphorylation
(Figure 2E). Western blot (Figures 2E and 2F, right panels),
in vitro kinase assays (Figure 2F, left panels) and immuno-
fluorescence (Figure 2G) confirmed the effectiveness of
the compound in blocking AurA activation.
Together, these data imply that activation of AurA by
HEF1 contributes to resorption of cilia at 2 and 18 hr fol-
lowing serum stimulation (Figures 2A–2E) and that active
AurA is necessary to stably complete the disassembly
process, but that HEF1 may not be the sole factor driving
AurA activation and ciliary resorption (Figure 2A). Further,
FACS analysis of cells with siRNA-depleted HEF1 or AurA
(Figure S4C), or drug-inhibited AurA (Figure 2H) indicated
that the blocked resorption of cilia at the 2 hr time point
does not reflect an indirect consequence of altered cell
cycle compartmentalization due to AurA inhibition. Cells
indeed show predictable siRNA- and drug-induced accu-
mulation in G2 at 18–24 hr after serum stimulation, which
may account for the reduced resorption at these time
points. However all cells at 2 hr after serum treatment
have similar cell cycle profiles, remaining predominantly
in G0/G1. Hence, the role of HEF1 and AurA at this early
nonmitotic time point represents an unexpected direct
action of these proteins.
AurA Activation Is Sufficient to Induce Rapid
Disassembly of Cilia
Next, as a direct approach to establish sufficiency of active
AurA to induce disassembly, we microinjected preacti-
vated wild-type AurA (aAurA), T288A AurA (a hypomorphic
mutant, (Satinover et al., 2004)), D274N AurA (an inactive
mutant), GST, or buffer alone, together with fluorescent
marker dye, into hTERT-RPE1 cells with preformed cilia.
Microinjection of aAurA rapidly induced thedisappearance
of cilia from cells maintained in low serummedium: essen-
tially as soon as cells could be fixed after microinjection,FGFR1 (IC50 120, 185, and 390 nM, respectively, [Soncini et al., 2006]). Results were confirmed using anti-glutamylated tubulin, as shown in
Figure S4D.
(E) Analysis performed in parallel with experiments described in D demonstrates PHA-680632 blocks appearance of T288-phospho-AurA (visualized
with antibody from BioLegend), and HEF1 phosphorylation (115 kDa form), in reference to DMSO () at the 2 and 24 hr time points. Black arrows
marks phosphorylated AurA, and hyperphosphorylated (p115) HEF1; gray arrow indicates p105 HEF1. See also Figure S1I.
(F) Cells were treated with indicated concentrations of the AurA inhibitor PHA-680632, and then AurA immunoprecipitated, and used for in vitro kinase
reactions (left) or whole cell lysates used for Western analysis with antibody to total or phosphorylated AurA (right).
(G) Immunofluorescence analysis of appearance of phospho-AurA at times indicated after serum stimulation in DMSO- or PHA-680632-treated cells.
DNA (blue), acetylated a-tubulin (red), and T288-phospho-AurA (green). In 18 hr DMSO/ph-AurA, an asterisk (*) marks a rare observation of phospho-
AurA at the base of a shortened cilium.
(H) FACS analysis of cells treated with DMSO vehicle or PHA-680632 at the times indicated after serum stimulation.Cell 129, 1351–1363, June 29, 2007 ª2007 Elsevier Inc. 1355
Figure 3. Microinjection of Active AurA Causes Rapid Loss of Cilia
(A) Microinjection of wild-type AurA, T288A or D274Nmutant AurA, or GST, or PBS buffer, into hTERT-RPE1 cells with preformed cilia. (), uninjected
controls. Time reflects minutes from injection to initiating fixation of slides. Experiments repeated three times, with >100 injected cells scored in each
experiment, error bars show SD.
(B) Cilia 45 min postinjection of AurA or D274N. Red, acetylated a-tubulin; blue, glutamylated a-tubulin (a second independent marker of cilia); blue,
DNA; green, Dextran488 indicates injected cells. High magnification images to right are from boxed cells; an asterisk (*) marks magnification of
uninjected cells.
(C) AurA andmutants (D274N, T288A) were incubated with histone H3 (17 kDa) andMBP (22 kDa) substrates in an in vitro kinase assay, confirming the
activity of kinase. +Lysate indicates thatmutantswere incubated for 3 hr at 4Cwith hTERT-RPE1 cell lysate, then pulled down and used for the kinase
assay.more than80%of injectedcells lackedcilia (Figures3Aand
3B). In contrast, injection of GST or buffer did not induce
loss of cilia. Of the two mutants, D274N did not induce
loss of cilia, while T288A caused eventual partial loss of
cilia (Figure 3A) and ciliary shortening (results not shown).
The ability of aAurA, T288A, and D274N paralleled the be-
havior of these proteins in in vitro kinase assays performed
in parallel to microinjections (Figure 3C). Whereas aAurA
was highly active and D274N was completely inactive,
T288A became weakly active following brief incubation
with cell lysates. Hence, the delayed resorption of cilia and
ciliary shortening inducedbyT288A likely reflects thegrad-1356 Cell 129, 1351–1363, June 29, 2007 ª2007 Elsevier Inc.ual emergence of an active pool of AurA followingmicroin-
jection.
HDAC6 Is Required for Ciliary Disassembly
Little is known about the cellular machinery necessary for
disassembling cilia. In seeking targets of AurA phosphor-
ylation that might be relevant to this process, we consid-
ered the possibility that the acetylated a-tubulin com-
monly used to visualize cilia might play an active role in
stabilizing the ciliary axoneme, based on reports that a-
tubulin deacetylation promoted the in vivo destabilization
of microtubules (Matsuyama et al., 2002). In particular,
Figure 4. HDAC6 Activity Is Necessary for Resorption of Cilia
(A) Treatment of hTERT-RPE1 cells with histone deacetylase inhibitors prevents ciliary resorption. Cells were incubated with indicated compounds
or vehicle (DMSO) at concentrations described in the Experimental Procedures for 2 hr prior to induction of ciliary disassembly. The assay was per-
formed three times, with an average of 100 cells counted/time point.
(B) TSA and tubacin increase intracellular levels of acetylated tubulin. Shown, Western blot with indicated antibodies showing levels of acetylated
tubulin in cells treated with TSA, tubacin, niltubacin, or vehicle (DMSO).
(C) GSK3b inhibitor and farnesyltransferase inhibitor (FTI) do not inhibit ciliary disassembly.
(D) Depletion of HDAC6 restricts serum-induced disassembly of cilia in hTERT-RPE1 cells transfected for 48 hr with siRNAs to HDAC6, HDAC2, or
a scrambled control.
(E) Western analysis of hTERT-RPE1 cells treated with siRNA to HDAC6, HDAC2, or scrambled control.
(F) Active AurA or PBS were microinjected into hTERT-RPE1 cells pretreated for 2 hr with tubacin or DMSO. Error bars in panels A, C, D, and F show
SD.histone deacetylase 6 (HDAC6) has been identified as an
important cytoplasmic tubulin deacetylase that influences
mitosis and chemotaxis through regulating tubulin stability
(Hubbert et al., 2002).
To assess whether altered regulation of tubulin acetyla-
tion might mediate HEF1/AurA signaling, we treated cili-
ated hTERT-RPE1 cells with small molecule deacetylase
inhibitors, and established the ciliary disassembly profile
(Figure 4A). Both the broad-spectrum HDAC inhibitor tri-
chostatin A (TSA), and tubacin, an inhibitor specifically
targeting HDAC6 (Hideshima et al., 2005), completely
blocked serum-induced ciliary disassembly, whereas nil-
tubacin, an inactive analog of tubacin, and vehicle alone
had no effect. Levels of acetylated tubulin were measured
in treated cells, confirming that these were increased in
cells treated with TSA and tubacin, but not in cells treated
with niltubacin or control vehicle (Figure 4B). As a control,
because both AurA and HDAC inhibitors blocked ciliarydisassembly, we considered the possibility that regulated
ciliary disassembly might be generally sensitive to signal-
ing inhibitors because of nonspecific toxicities. However,
serum induced disassembly with a normal profile in cells
treated with inhibitors of GSK-3b and farnesyltransferase
(FTI), indicating that blocked ciliary disassembly was spe-
cific response to impaired AurA and HDAC6 signaling
(Figure 4C).
To further confirm a specific requirement for HDAC6,we
next established that cilia do not disassemble in serum-
treated cells with siRNA-depleted HDAC6 (Figures 4D
and 4E). Finally, we have microinjected aAurA into ciliated
cells pretreated for 2 hr with tubacin (Figure 4F). Tubacin
pretreatment substantially limited the ability of microin-
jected AurA to disassemble cilia. Initial disassembly was
slower, and in some cases transient, with a significant per-
centage of injected cells re-forming cilia by 1 hr after injec-
tion. As for AurA, neither tubacin treatment nor siRNA toCell 129, 1351–1363, June 29, 2007 ª2007 Elsevier Inc. 1357
Figure 5. Direct Phosphorylation by AurA Activates HDAC6 Tubulin Deacetylase Activity
(A) hTERT-RPE1 whole-cell lysate (WCL) of cells treated with AurA inhibitor PHA 680632 (+) or with vehicle () was analyzed byWestern blot directly,
or following immunoprecipitation (IP) with antibody to AurA, using antibodies as indicated. The immunoprecipitation of the slow-migrating form of
HDAC6 is not impacted by treatment of cells with PHA-680632, indicating that it most likely represents HDAC6 modified by an additional (unknown)
cellular kinase/s.
(B) AurA phosphorylates HDAC6. In vitro translated and immunoprecipitated HDAC2 or HDAC6 (HD2, HD6), or recombinant GST (), weremixed with
recombinant AurA and used in an in vitro kinase assay. Reaction was split and used for autoradiography (32P) or Western Blot (WB).
(C) In vitro translated HDAC2 or HDAC6 (HD2, HD6) were immunoprecipitated. IPs were mixed with AurA (+) or buffer (), then used for either an
in vitro tubulin deacetylation assay, or in an in vitro kinase assay using g-32P-ATP (see Experimental Procedures). Reaction mix was visualized by
Western blot and by autoradiography, as indicated.
(D) HDAC6 localizes to disassembling cilia 2 hr after serum treatment. The scale bar represents 15 mM.HDAC6 influenced cell cycle profile at 2 hr after serum
stimulation, although both treatments led to accumulation
in G2 at the later time point (Figures S4F and S4G). As a
final control, we again used antibody to glutamylated
tubulin as an independent means of scoring ciliary disas-
sembly (Figure S4E). The results of these experiments are
equivalent to those obtained using antibody to acetylated
a-tubulin (Figures S5A–S5C). Based on these data, we
concluded that HDAC6 is an important downstream
AurA effector for ciliary disassembly.
AurA Phosphorylates HDAC6 to Activate
Tubulin Deacetylase activity
Taken together, our data suggested that the mechanism
of ciliary disassembly by AurA requires intact HDAC6 de-
acetylation activity, to destabilize microtubules. AurA-de-
pendent regulation of tubulin deacetylation may be direct
or indirect. Importantly, although microinjection of AurA
induced loss of ciliary a-acetylated tubulin as cilia disas-1358 Cell 129, 1351–1363, June 29, 2007 ª2007 Elsevier Inc.semble, the nonciliary a-acetylation of cytoplasmic micro-
tubule networks were unaffected, suggesting a specific
action of AurA andHDAC6 at the cilia (Figure S5C). Further
supporting this idea, HDAC6 localized to cilia in serum-
starved cells and during the ciliary disassembly process
(Figure 5D and unpublished data), providing a ready target
for AurA phosphorylation. Demonstrating a direct AurA-
HDAC6 connection, antibody to AurA coimmunoprecipi-
tated HDAC6 from hTERT-RPE1 cells (Figure 5A). AurA-
HDAC6 coimmunoprecipitation was not eliminated by
pretreatment of cells with PHA-680632, indicating that
the association was not regulated by AurA activation
status (Figure 5A).
To directly determine whether HDAC6might be an AurA
substrate, recombinant activated AurA was used in an
in vitro kinase assay with purified HDAC6, HDAC2, or
GST, as in (Pugacheva and Golemis, 2005). AurA phos-
phorylated HDAC6, but not HDAC2 or the GST negative
control (Figure 5B). We next immunoprecipitated in vitro
Figure 6. A Role for IFT Proteins in AurA-Induced Ciliary Resoprtion
(A) Western blot demonstrating siRNA depletion of IFT88 (siIFT88) in ciliated hTERT-RPE1 cells at times following serum treatment, relative to scram-
ble-depleted control.
(B) Immunofluorescence matching Figure 6A at time 0, indicating relative degree of depletion of IFT88 at the basal body. Anti-acetylated a-tubulin,
red; IFT88, green.
(C) Ciliary disassembly in IFT88- depleted (s88) versus Scr-depleted cells, at 0, 12, or 18 hr after serum treatment, based on the total cell population
(gray bars). Black bars (right) indicate percent ciliated cells at time 0 calculated specifically from cells confirmed by immunofluorescence to have sig-
nificant IFT88 staining (88+), or to be well-depleted for IFT88 (88), error bars show SD.
(D) Cells treated with scrambled (Scr) or AurA-targeting (siAurA) siRNAs, or with PHA-680632 were fixed 2 hr after serum-initiated disassembly.
Shown, immunofluorescence indicating cilia (anti-acetylated a-tubulin, red) and IFT88 (green). Insets are enlargements of boxed ciliary structures;
arrows indicate cells without cilia. The scale bar represents 10 mm.translated HDAC6 and a negative control, HDAC2, and
gauged the relative ability of AurA to phosphorylate these
proteins, and stimulate a tubulin deacetylase activity, in a
defined in vitro assay. In reactions containing comparable
levels of HDAC2 and HDAC6, only HDAC6 was phosphor-
ylated by AurA (Figure 5C). Moreover, AurA-phosphory-
lated HDAC6 was much more potent than unphosphory-
lated HDAC6 in deacetylating a-tubulin (Figure 5C).
These results lead us to conclude that AurA phosphoryla-
tion of HDAC6 stimulates HDAC6 deacetylase activity.
Ciliary Disassembly and Intraflagellar Transport
Intraflagellar transport (IFT) proteins perform important
roles in mediating transport of proteins to and from the
apical tip of cilia, and in many cases mutations in IFT pro-
teins have been linked to ciliary dysfunction, loss of cilia,and pathological conditions (Sloboda, 2005). In contrast
to depletion of HEF1 or AurA, depletion of representative
IFT proteins IFT88 (Figures 6A–6C) and IFT20 (Figure S6)
limits the initial formation of cilia in hTERT-RPE1 cells, sim-
ilar to reports in other cell types (Follit et al., 2006; Pazour
et al., 2000). Based on immunofluorescence, cilia were
only observed in IFT-depleted cells that retain at least
some detectable IFT protein (Figure 6C). This clear re-
quirement of IFT proteins for ciliary assembly hinders the
dissection of the contribution of these proteins in disas-
sembly. However, intriguingly, the existing cilia in IFT88-
or IFT20-depleted cells undergo minimal disassembly fol-
lowing serum stimulation, with the difference particularly
noticeable at the early (2h) time point (Figures 6C, S6). Fur-
ther, depletion or inhibition of AurA alters the localization
of IFT88 during the ciliary disassembly process. InCell 129, 1351–1363, June 29, 2007 ª2007 Elsevier Inc. 1359
Figure 7. Working Model
(A) Aurora A (AurA) and low levels of HEF1 are
localized to the basal body of quiescent, cili-
ated cells.
(B) Our data are consistent with a model in
which growth factors induce HEF1 expression,
promoting HEF1-dependent activation of Au-
rora A. This results in phosphorylation of ciliary
HDAC6 6 (H6) by Aurora A, thereby inducing
ciliary resorption.untreated cells, IFT88 is seen intensely at the basal body
and more diffusely along the axoneme of residual cilia
two hours after serum stimulation, whereas in cells lacking
active AurA, IFT88 accumulates at both the basal body
and apical tip at this time point (Figure 6D). It is likely
that as in Chlamydomonas (Pan and Snell, 2005), IFT sig-
naling mediates some aspects of ciliary disassembly.
DISCUSSION
Cilia and flagella have been described as cellular ‘‘anten-
nas’’, sensing a multiplicity of extracellular stimuli to in-
duce an intracellular response (Singla and Reiter, 2006).
In addition to undergoing regulated resorption induced
by extracellular cues, for over four decades cilia have been
known to be dynamically resorbed and resynthesized
throughout the cell cycle. Taken in sum, our data suggest a
model (Figure 7) in which the serumgrowth factor-induced
activation of a HEF1-AurA complex allows AurA to phos-
phorylate and activate HDAC6, which destabilizes the
ciliary axoneme by deacetylating tubulin. Unexpectedly,
activation of AurA is a central component of this cascade
even during the G1 resorption wave, indicating a nonmi-
totic activity for AurA in animals.
An important finding of this work is the novel connection
between AurA and HDAC6. HDAC6 tightly interacts with
a and b tubulins through its HDAC domain, which may re-
strict its enzymatic activity, based on reports that taxol
treatment causes HDAC6 to accumulate on microtubules,
and is accompanied by increased tubulin acetylation
(Zhang et al., 2003). Localized phosphorylation by AurA
may increase the turnover of HDAC6 at microtubules,
thus increasing the active pool of HDAC6 at cilia. Interest-
ingly, studies in Chlamydomonas indicate that an impor-
tant element of flagellar resorption is destabilization of the
microtubule-based axoneme, suggesting this signaling
cascade may be evolutionarily conserved (Pan and Snell,
2005; Pan et al., 2004). Further supporting the idea of con-
servation, the C. elegans gene MEC-12 encodes an a-tu-
bulin variant that is specifically required only in mechano-
sensing neurons, which depend on intact cilia: MEC-12 is
the only a-tubulin in this species with a conserved site for
acetylation (Fukushige et al., 1999). Interestingly, HDAC6
has been reported to associate with protein phosphatase
1 (PP1) (Brush et al., 2004), which bindsmicrotubules (Liao
et al., 1998), and dephosphorylates and inactivates AurA
kinase. Such feedback may limit AurA activation at cilia.1360 Cell 129, 1351–1363, June 29, 2007 ª2007 Elsevier Inc.A number of growth stimuli induce HEF1 expression and
phosphorylation, influencing its protein interactions. These
include PDGF, which is here shown to partially induce cil-
iary disassembly (Natarajan et al., 2006). Intriguingly, re-
cent studies of p130Cas, a protein structurally similar to
HEF1, indicate that p130Cas acts as a stretch sensor;
HEF1 contains all sequence motifs necessary for similar
function (Kostic and Sheetz, 2006). As one major function
of cilium is to sense fluid flow, and overly persistent flow
has been reported to induce ciliary disassembly (Iomini
et al., 2004), stretch sensation may be an important action
of HEF1. Our data suggest that HEF1 both activates AurA
and stabilizes the protein from degradation; it will be inter-
esting to determine if the HEF1 scaffolding activity also
contributes to AurA interaction with its effector HDAC6.
Our data also indicate that AurA activity influences IFT88
localization during disassembly, and suggest integrity of
the IFT system is important for the disassembly process
in animals, as in Chlamydomonas (Pan and Snell, 2005).
Our establishment of a HEF1-AurA-HDAC6 cascade at
cilia also informs the understanding of themitotic activities
of these proteins. Dynamic changes in microtubule acety-
lation and deacetylation characterize the stages of mito-
sis, and HDAC inhibitors that inhibit family members with
microtubule deacetylase activity induce mitotic arrest
(Blagosklonny et al., 2002). The identification here of
HDAC6 as an AurA target suggests that HEF1-AurA regu-
lation of tubulin deacetylation at mitosis through HDAC6
might offer a mechanism to fine-tune the mechanical
properties of the mitotic spindle. This signaling cascade
may also influence re-establishment of focal adhesions
at and following cytokinesis, given the growing apprecia-
tion of the role of microtubules in guiding the formation
of these structures (Ezratty et al., 2005; Strickland et al.,
2005). Further, one intriguing possibility is that the com-
mon use of an AurA-HEF1-HDAC6 switch at the basal
body of quiescent cells and the centrosome of G2/M cells
may serve as part of a checkpoint mechanism coordinat-
ing responsiveness to extracellular cues at different points
in cell cycle. In this context, our observation that inhibition
of AurA causes appearance of mitotically arrested cells
possessing both spindles and cilia (results not shown)may
reflect triggering of such a centrosomally based check-
point.
These results also have implications for the understand-
ing and treatment of cancer. Tumor cells commonly do not
have cilia, and both HEF1 and AurA are often upregulated
in cancer. The roles for these proteins at the centrosome
and focal adhesions described earlier already offer two
mechanisms by which these proteins may promote tumor
initiation and progression. The current study indicates
a third mechanism, in which elevation of HEF1 or AurA in
tumors may destabilize cilia, thus conditioning cellular re-
sponse to external cues and impacting multiple signaling
pathways. Further, AurA is regarded as a promising che-
motherapeutic target, with agents inhibiting this protein
currently in clinical trials (Andrews, 2005). TSA and other
broad-spectrum agents targeting HDACs are used in the
clinic (Vanhaecke et al., 2004), with more focused agents
such as tubacin in preclinical development (Hideshima
et al., 2005). Our data suggest that AurA- or HDAC-tar-
geted drugs may have previously unappreciated in vivo
effects involving cilia, that may contribute to the observed
efficacy and/or side effects of these agents.
PKD is one of the best-described cilia-related diseases
(Wilson, 2001), with mutation of the cilia-localized poly-
cystin proteins 1 and 2 (PKD1 and PKD2) responsible for
the significant majority of PKD patients. p130Cas interacts
directly with complexes containing PKD1 and PKD2, and
also with nephrocystins, cilia-associated proteins that
are mutated in a second renal cystic syndrome, nephro-
nophthisis (Benzing et al., 2001). Although an association
of HEF1 with these proteins has never been assessed,
HEF1 is abundant in the kidney and conserves many pro-
tein interaction sequences with p130Cas. It is also tanta-
lizing to consider that closer connections exist between
dysplastic disorders leading to cysts and cancer than
have previously been appreciated. One of the surprising
results of a recent large study to analyze the cancer ge-
nome was the identification of the PKHD1 protein, a ciliary
protein which is mutant in autosomal recessive PKD, as
commonly mutated in colorectal cancer (Sjoblom et al.,
2006). Overall, deregulated AurA/HEF1/HDAC6 signaling
may have broad implications for studies of human devel-
opment and disease.
EXPERIMENTAL PROCEDURES
Cell Culture and siRNA
hTERT-RPE1 cells were grown in DMEM with 10% fetal bovine serum
(FBS). For analysis of ciliary disassembly, cells were plated at 30%
confluence in plates containing glass cover slips, and starved for
48 hr (in Opti-MEM or regular DMEM, without added serum) to induce
cilia formation, followed by treatments described in Results. Details of
siRNAs used for depletion of HEF1, AurA, HDAC6, HDAC2, IFT88,
IFT20, and control siRNAs, are available on request. For siRNA treat-
ment, cells were initially plated in DMEM/10%FBS in plates containing
cover slips, and 12 hr later siRNA transfection was performed in Opti-
MEM with Oligofectamine (Invitrogen) according to manufacturer
recommendations, and fixed 48 hr after transfection, following treat-
ments indicated in Results. The remaining cells on plate were lysed,
then either directly analyzed by Western blot analysis, or used for
immunoprecipitation (IP)-kinase reaction to measure AurA activity.
Drug Inhibition Experiments
The Aurora kinase inhibitor PHA-680632, GSK3b-inhibitor 1 (Calbio-
chem), FTI-277 (Calbiochem), Tubacin, Niltubacin or DMSO vehicle
were added to hTERT-RPE1 cells 2 hr prior to the initiation of ciliary dis-
assembly. After initial titration experiments to establish effective range,PHA-680632 was used at 0.5 mM, Tubacin and Niltubacin at 2 mM,
GSK3b-inhibitor 1 at 2 mM, FTI-277 at 50nM concentration for the
experiments described.
Protein Expression, Western Blotting, and Immunoprecipitation
For microinjection, recombinant glutathione-S-transferase (GST), GST
fused AurA mutants T288A and D274N) produced from BL21 (DE3)
bacteria were purified using the MicroSpin GST Purification Module
(Amersham Biotech.). Purified recombinant AurA was purchased
from Upstate; this AurA was preactivated based on incubation with
ATP. Mutationally inactive AurA (T288A,) was also made using a
baculoviral expression system (Invitrogen), and was purified by
Ni-Sepharose 6FF (Amersham).
To prepare lysates for Western blotting and IP, mammalian cells
were disrupted by M-PER lysis buffer (Pierce) supplemented with
EDTA-free protease inhibitor cocktail (Roche). Lysates used for IP
were incubated overnight with antibody at 4C, subsequently incu-
bated for 2 hr with protein A/G-sepharose (Pierce), washed, and re-
solved by SDS-PAGE.Western blotting was performed using standard
procedures and proteins visualized using the West-Pico system
(Pierce). Antibodies used included mouse monoclonal antibody
(mAb) anti-HEF1 2G9 (Pugacheva and Golemis, 2005), anti-a-tubulin
mAb (Sigma), anti-AurA (BD Bioscience) for Western blotting, anti-
AurA rabbit polyclonal (Cell Signaling) for IP, anti-Phospho-AurA/
T288 (BioLegend), anti-Phospho-AurA/T288 (Cell Signaling), anti-
HDAC6 rabbit polyclonal (Upstate; 1:5000), anti-HDAC2 rabbit poly-
clonal (Invitrogen) and mAb anti-b-actin (AC15, Sigma), anti-IFT88
and anti-IFT20. Secondary horseradish peroxidase (HRP)-conjugated
antibodies were from Amersham Biotech.
Immunofluorescence
Cells were fixed with 4% paraformaldehyde (10 min) then methanol
(5 min), permeabilized with 1%Triton-X100 in PBS, blocked in 13
PBS, 3% BSA, and incubated with antibodies using standard proto-
cols. Primary antibodies included rabbit polyclonal anti-Aurora A and
anti-phospho-AuroraA/T288, (Cell Signaling), mouse mAb anti-HEF1
(14A11), polyclonal anti-g-tubulin (Sigma), anti-a-tubulin mAb (Sigma),
anti-acetylated a-tubulin mAb (clone 6-11B-1, Sigma, and clone
K(Ac)40 Biomol), anti-IFT88 and anti-IFT20 (gifts of G. Pazour), mouse
anti-glutamylated tubulin (Sigma), and anti-HDAC6 (Upstate). Second-
ary antibodies labeled with Alexa-488, Alexa-568, and Alexa-633, and
TOTO-3 dye to stain DNA, were from Molecular Probes/ Invitrogen.
DNA was costained in some experiments by propidium iodine (Sigma)
or Draq5 (Alexis). Confocal microscopy was performed using a
Radiance 2000 laser scanning confocal microscope (Carl Zeiss,
Thornwood, NY) coupled to a Nikon Eclipse E800 upright microscope
(Nikon). Statistical analysis of data by one-way ANOVAwas performed
using GraphPad Instat 3.0 (San Diego, CA).
Microinjection
Microinjections were performed on a Nikon TE300Microscope (Nikon,
Melville, NY) that was equipped with an Eppendorf Transjector 5246
semiautomatic microinjector andmicromanipulator (Eppendorf, West-
bury, NY). Cells were plated on gridded coverslips (Belco) and starved
for 48 hr before cytoplasmic microinjection of 0.05mM preactivated
AurA (Upstate), inactive AurA (T288A) and (D274N), GST protein, or
buffer. Proteins were prefiltered through a 0.2 mmMillipore membrane
and mixed with Dextran Green488 (Molecular Probes) to mark injected
cells. Injected cells were incubated at 37C before fixation. Typically,
150 cells were microinjected in each of 3 experiments.
Kinase and Tubulin Deacetylation Assays
In vitro kinase assays were performed using recombinant active AurA
(Upstate), mutationally inactive AurA purified from baculovirus and
BL21(DE3) bacteria, or endogenous AurA immunoprecipitated from
mammalian cells. A standard kinase reaction with g-32P(ATP) and his-
tone H3 andMBP (Upstate) substrates was done as in (Pugacheva andCell 129, 1351–1363, June 29, 2007 ª2007 Elsevier Inc. 1361
Golemis, 2005). For deacetylase assays, HDAC6 and HDAC2 were in
vitro translated using a TnT-Coupled Reticulocyte Lysate System
(Promega), immunoprecipitated, and incubated with/without active
AurA(Upstate) in the presence of (25mg) stabilized microtubules pre-
pared from purified bovine brain tubulin (Cytoskeleton) to measure
deacetylase activity (as in (Hubbert et al., 2002)) and with g-32P-ATP
(Perkin-Elmer) in AurA reaction buffer. 1/10 volume of sampleswere re-
served for Western blotting.
Supplemental Data
Supplemental Data include six figures and canbe foundwith this article
online at http://www.cell.com/cgi/content/full/129/7/1351/DC1/.
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